T’ai chi for individuals with COPD: an ancient wisdom for a 21st century disease? Source: Eur Respir J 2013; 41: 1005-1007 Year: 2013
Cystic fibrosis newborn screening programme in central Catalonia area (Spain). What have we learnt 8 years later? Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008
Infection and remodelling: a 21st century model of bronchiectasis? Source: Eur Respir J 2011; 38: 758-760 Year: 2011
Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years Source: Eur Respir J, 50 (4) 1701209; 10.1183/13993003.01209-2017 Year: 2017
Update on tuberculosis: TB in the early 21st century Source: Eur Respir Rev 2011; 20: 71-84 Year: 2011
The impact of genotype on clinical course of cystic fibrosis (CF) in adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013
Nontuberculous mycobacteria (NTM) in Cystic fibrosis (CF) patients over the last decade: real-life data from Verona CF center Source: Virtual Congress 2021 – Cystic fibrosis Year: 2021
Lung transplantation for cystic fibrosis – ten years‘ experience in Hungary Source: Eur Respir J 2007; 30: Suppl. 51, 386s Year: 2007
Trends in cystic fibrosis (CF) survival in South Africa over 40 years Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021
ABPA syndrome (ABPAs) in CF: FEV1 decline, infectious exacerbations and BMI before and after the year of diagnosis (index year), a case control study Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014
Childhood asthma phenotypes in the twenty-first century Source: Breathe 2014; 10:100-108 Year: 2014
Evidence incidence of cystic fibrosis: A 30-year study in Krasnoyarsk, Russia Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013
The changes of asthma control and management, patients’perception for the past decade in China Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018
Case study in cystic fibrosis: the US CF Foundation research and clinical development programmes Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines Year: 2014
Cystic fibrosis mortality and survival in the UK: 1947-2003 Source: Eur Respir J 2007; 29: 522-526 Year: 2007
Cystic fibrosis in South Africa: spectrum of disease and determinants of outcome Source: ERJ Open Res, 7 (3) 00856-2020; 10.1183/23120541.00856-2020 Year: 2021
Non cystic fibrosis bronchiectasis in a pediatric clinic – 5 year evaluation Source: Eur Respir J 2006; 28: Suppl. 50, 490s Year: 2006
Clinical features of adult’s cystic fibrosis in the Republic of Belarus Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013
Lung tuberculosis in Serbia and antituberculosis drug resistance during last five years of 20th century Source: Eur Respir J 2003; 22: Suppl. 45, 342s Year: 2003
The effect of transition from a paediatric to adult cystic fibrosis (CF) centre on clinical status and hospital attendance Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016